OPKO Health Return on Investment 2011-2025 | OPK
Current and historical return on investment (ROI) values for OPKO Health (OPK) over the last 10 years.
| OPKO Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $-0.11B | $1.63B | -6.71% |
| 2025-06-30 | $-0.15B | $1.62B | -8.50% |
| 2025-03-31 | $-0.15B | $1.64B | -8.68% |
| 2024-12-31 | $-0.15B | $1.79B | -8.97% |
| 2024-09-30 | $-0.19B | $1.83B | -11.40% |
| 2024-06-30 | $-0.27B | $1.57B | -16.55% |
| 2024-03-31 | $-0.20B | $1.60B | -11.93% |
| 2023-12-31 | $-0.16B | $1.60B | -9.27% |
| 2023-09-30 | $-0.14B | $1.66B | -8.24% |
| 2023-06-30 | $-0.17B | $1.75B | -9.47% |
| 2023-03-31 | $-0.19B | $1.76B | -10.23% |
| 2022-12-31 | $-0.23B | $1.77B | -12.39% |
| 2022-09-30 | $-0.23B | $1.77B | -12.65% |
| 2022-06-30 | $-0.11B | $1.93B | -5.70% |
| 2022-03-31 | $-0.09B | $1.83B | -4.81% |
| 2021-12-31 | $0.02B | $1.87B | 0.99% |
| 2021-09-30 | $0.13B | $1.95B | 6.81% |
| 2021-06-30 | $0.12B | $1.93B | 6.07% |
| 2021-03-31 | $0.14B | $1.92B | 7.29% |
| 2020-12-31 | $0.06B | $1.89B | 3.12% |
| 2020-09-30 | $-0.10B | $1.84B | -5.75% |
| 2020-06-30 | $-0.17B | $1.81B | -9.11% |
| 2020-03-31 | $-0.24B | $1.76B | -13.00% |
| 2019-12-31 | $-0.27B | $1.83B | -14.45% |
| 2019-09-30 | $-0.25B | $1.85B | -13.24% |
| 2019-06-30 | $-0.25B | $1.92B | -12.94% |
| 2019-03-31 | $-0.20B | $1.97B | -10.79% |
| 2018-12-31 | $-0.17B | $1.85B | -9.20% |
| 2018-09-30 | $-0.24B | $1.85B | -12.81% |
| 2018-06-30 | $-0.25B | $1.87B | -13.14% |
| 2018-03-31 | $-0.28B | $1.88B | -13.73% |
| 2017-12-31 | $-0.28B | $1.87B | -13.38% |
| 2017-09-30 | $-0.19B | $2.12B | -9.04% |
| 2017-06-30 | $-0.17B | $2.14B | -7.88% |
| 2017-03-31 | $-0.12B | $2.15B | -5.41% |
| 2016-12-31 | $-0.10B | $2.14B | -4.67% |
| 2016-09-30 | $-0.03B | $2.16B | -1.54% |
| 2016-06-30 | $-0.02B | $2.06B | -0.79% |
| 2016-03-31 | $-0.07B | $2.05B | -3.93% |
| 2015-12-31 | $-0.10B | $2.03B | -6.65% |
| 2015-09-30 | $-0.12B | $2.01B | -10.09% |
| 2015-06-30 | $-0.16B | $0.94B | -16.95% |
| 2015-03-31 | $-0.17B | $0.92B | -17.56% |
| 2014-12-31 | $-0.15B | $0.97B | -14.31% |
| 2014-09-30 | $-0.15B | $1.00B | -14.29% |
| 2014-06-30 | $-0.12B | $1.03B | -11.30% |
| 2014-03-31 | $-0.10B | $1.06B | -11.08% |
| 2013-12-31 | $-0.08B | $1.09B | -9.82% |
| 2013-09-30 | $-0.05B | $1.08B | -9.94% |
| 2013-06-30 | $-0.04B | $0.50B | -13.79% |
| 2013-03-31 | $-0.04B | $0.60B | -14.75% |
| 2012-12-31 | $-0.04B | -27.92% | |
| 2012-09-30 | $-0.04B | $0.18B | -19.55% |
| 2012-06-30 | $-0.03B | $0.17B | -19.94% |
| 2012-03-31 | $-0.03B | $0.18B | -19.28% |
| 2011-12-31 | $-0.02B | $0.19B | -17.39% |
| 2011-09-30 | $-0.01B | $0.11B | -13.99% |
| 2011-06-30 | $-0.01B | $0.11B | -16.81% |
| 2011-03-31 | $-0.01B | $0.13B | -35.20% |
| 2010-12-31 | $-0.01B | 0.00% | |
| 2010-09-30 | $-0.02B | -136.17% | |
| 2010-06-30 | $-0.02B | -57.14% | |
| 2010-03-31 | $-0.02B | -37.99% | |
| 2009-12-31 | $-0.02B | $0.05B | -47.57% |
| 2009-09-30 | $-0.03B | $0.08B | -76.32% |
| 2009-06-30 | $-0.03B | $0.05B | -131.91% |
| 2009-03-31 | $-0.04B | $0.01B | -269.09% |
| 2008-12-31 | $-0.04B | $0.01B | -219.72% |
| 2008-09-30 | $-0.04B | $0.02B | -179.31% |
| 2008-06-30 | $-0.03B | $0.01B | -165.71% |
| 2008-03-31 | $-0.03B | $0.02B | -190.16% |
| 2007-12-31 | $-0.27B | $0.03B | -2101.96% |
| 2007-09-30 | $-0.01B | $0.00B | -171.43% |
| 2007-06-30 | $-0.01B | $0.01B | -258.82% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | 0.00% | |
| 2006-09-30 | $-0.25B | 0.00% | |
| 2006-06-30 | $-0.25B | 0.00% | |
| 2006-03-31 | $-0.25B | 0.00% | |
| 2005-12-31 | $0.00B | 0.00% | |
| 2005-09-30 | $0.00B | 0.00% | |
| 2005-06-30 | $0.00B | 0.00% | |
| 2005-03-31 | $0.00B | 0.00% | |
| 2004-12-31 | $0.00B | 0.00% | |
| 2004-09-30 | $0.00B | 0.00% | |
| 2004-06-30 | $-0.01B | -200.00% | |
| 2004-03-31 | $-0.01B | -112.00% | |
| 2003-12-31 | $-0.01B | -70.00% | |
| 2003-09-30 | $-0.01B | $0.01B | -64.29% |
| 2003-06-30 | $-0.01B | $0.01B | -62.50% |
| 2003-03-31 | $-0.01B | $0.02B | -54.05% |
| 2002-12-31 | $-0.01B | $0.02B | -52.38% |
| 2002-09-30 | $-0.01B | $0.02B | -38.30% |
| 2002-06-30 | $-0.01B | $0.02B | -48.65% |
| 2002-03-31 | $-0.01B | $0.03B | -78.43% |
| 2001-12-31 | $-0.01B | $0.03B | -153.85% |
| 2001-09-30 | $-0.01B | 0.00% | |
| 2001-06-30 | $-0.01B | 0.00% | |
| 2001-03-31 | $-0.01B | 0.00% | |
| 2000-12-31 | $-0.01B | 0.00% | |
| 2000-09-30 | $-0.01B | 0.00% | |
| 2000-06-30 | $-0.01B | 0.00% | |
| 2000-03-31 | $-0.01B | 0.00% | |
| 1999-12-31 | $0.00B | 0.00% | |
| 1999-09-30 | $0.00B | 0.00% | |
| 1999-06-30 | $0.00B | 0.00% | |
| 1999-03-31 | $0.00B | 0.00% | |
| 1998-12-31 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.975B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.087B | 25.32 |
| Intuitive Surgical (ISRG) | United States | $195.983B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $53.421B | 53.05 |
| Edwards Lifesciences (EW) | United States | $49.175B | 32.97 |
| Alcon (ALC) | Switzerland | $37.787B | 25.54 |
| IQVIA Holdings (IQV) | United States | $36.805B | 20.52 |
| Mettler-Toledo (MTD) | United States | $28.374B | 33.20 |
| STERIS (STE) | Ireland | $25.225B | 26.04 |
| DexCom (DXCM) | United States | $22.812B | 31.45 |
| Waters (WAT) | United States | $22.503B | 29.76 |
| Hologic (HOLX) | United States | $16.490B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.194B | 23.49 |
| Penumbra (PEN) | United States | $10.907B | 76.72 |
| Masimo (MASI) | United States | $7.898B | 25.31 |
| Sysmex ADR (SSMXY) | Japan | $6.137B | 19.50 |
| Glaukos (GKOS) | United States | $5.077B | 0.00 |
| Teleflex (TFX) | United States | $4.590B | 7.31 |
| TransMedics (TMDX) | United States | $3.875B | 45.91 |
| Veracyte (VCYT) | United States | $3.105B | 35.39 |
| Alphatec Holdings (ATEC) | United States | $2.952B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.929B | 15.82 |
| Integer Holdings (ITGR) | United States | $2.351B | 11.04 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| Nihon Kohden (NHNKY) | Japan | $1.794B | 15.66 |
| Elekta AB (EKTAY) | Sweden | $1.692B | 16.39 |
| PROCEPT BioRobotics (PRCT) | United States | $1.625B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.243B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.196B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.087B | 51.77 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.914B | 4.95 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.524B | 30.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.516B | 10.30 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.409B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.92 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Semler Scientific (SMLR) | United States | $0.304B | 2.29 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.118B | 0.00 |
| Neuronetics (STIM) | United States | $0.113B | 0.00 |
| Accuray (ARAY) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.07 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |